利用机器学习识别儿童慢性肾脏病病因的代谢组学特征
该研究对702名CKD患儿血浆进行非靶向代谢组学定量,采用Lasso回归筛选特征并调整临床协变量,用四种机器学习方法在80%训练集和20%验证集上建模。机器学习模型优于无技能预测,识别出FSGS与鞘磷脂-神经酰胺轴及缩醛磷脂代谢相关,梗阻性尿路病与肠道微生物来源的组氨酸代谢物相关。
要点
- 机器学习模型在验证集上优于无技能预测,可区分儿童CKD病因。
- FSGS与鞘磷脂-神经酰胺轴及缩醛磷脂代谢失调相关。
- 梗阻性尿路病与肠道微生物来源的组氨酸代谢物相关。
核心结论
- 机器学习模型基于CKD病因识别出代谢组学特征,鞘磷脂-神经酰胺和缩醛磷脂代谢失调与FSGS相关,肠道微生物来源的组氨酸代谢物与梗阻性尿路病相关。
研究设计与样本
- 对702名Chronic Kidney Disease in Children研究参与者的血浆进行非靶向代谢组学定量(GC-MS/LC-MS,Metabolon),其中FSGS=63、梗阻性尿路病=122、发育不全/发育不良/增生不全=109、反流性肾病=86。
- 采用Lasso回归进行特征选择并调整临床协变量,应用逻辑回归、支持向量机、随机森林和极端梯度提升四种方法分层显著性。
- 机器学习训练在总队列80%子集上进行,并在20%留出子集上验证,重要特征基于在至少两种建模方法中显著进行选择。
- 进行通路富集分析以识别与CKD病因相关的代谢亚通路。
主要发现
- 机器学习模型在留出子集上以受试者工作特征曲线下面积、精确率-召回率曲线下面积、F1分数和马修斯相关系数评估,优于无技能预测。
- 基于病因识别出代谢组学特征:FSGS与鞘磷脂-神经酰胺轴相关,FSGS还与单个缩醛磷脂代谢物及该亚通路相关。
- 梗阻性尿路病与肠道微生物来源的组氨酸代谢物相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Untargeted plasma metabolomic profiling combined with machine learning (ML) may lead to discovery of metabolic profiles that inform our understanding of pediatric CKD causes. We sought to identify metabolomic signatures in pediatric CKD based on diagnosis: FSGS, obstructive uropathy (OU), aplasia/dysplasia/hypoplasia (A/D/H), and reflux nephropathy (RN). METHODS: Untargeted metabolomic quantification (GC-MS/LC-MS, Metabolon) was performed on plasma from 702 Chronic Kidney Disease in Children study participants (n: FSGS=63, OU=122, A/D/H=109, and RN=86). Lasso regression was used for feature selection, adjusting for clinical covariates. Four methods were then applied to stratify significance: logistic regression, support vector machine, random forest, and extreme gradient boosting. ML training was performed on 80% total cohort subsets and validated on 20% holdout subsets. Important features were selected based on being significant in at least two of the four modeling approaches. We additionally performed pathway enrichment analysis to identify metabolic subpathways associated with CKD cause. RESULTS: ML models were evaluated on holdout subsets with receiver-operator and precision-recall area-under-the-curve, F1 score, and Matthews correlation coefficient. ML models outperformed no-skill prediction. Metabolomic profiles were identified based on cause. FSGS was associated with the sphingomyelin-ceramide axis. FSGS was also associated with individual plasmalogen metabolites and the subpathway. OU was associated with gut microbiome-derived histidine metabolites. CONCLUSION: ML models identified metabolomic signatures based on CKD cause. Using ML techniques in conjunction with traditional biostatistics, we demonstrated that sphingomyelin-ceramide and plasmalogen dysmetabolism are associated with FSGS and that gut microbiome-derived histidine metabolites are associated with OU.
引用
- Lee AM, Hu J, Xu Y, et al. Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology. J Am Soc Nephrol. 2022. PMID: 35017168. doi:10.1681/ASN.2021040538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。